Investing carries serious risks, including partial or total loss of capital. Please read the Information Note and the Risk factors and login before investing.

Neutraceutical food patent company

Equity Belgium 73 investors Tax Shelter applicable

Tax Shelter

Making industrial food cholesterol-friendly
Information Note Terms & Conditions
Pre money valuation
Equity offered
Amount raised
Committed by co-investors
64 days
Minimum target
188% funded

Eric B

Who will own the IP related to the patents? Normaphar or NFPC? If Normaphar keeps it, under which conditions will NFPC be allowed to use the IP?

Coralie B

Dear Eric,
NFPC will own the IP.
NFPC will purchase the patent to Normaphar (200K€). This amount has been evaluated and certified by an external auditor.
If you need further explanation, please don't hesitate to contact me by email :